Trial · NCT07054801
IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage
NCT07054801, Phase 2, Recruiting, Daniel Raper, MBBS
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage. Trials, record NCT07054801. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07054801
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage
- NCT number
- NCT07054801
- Status
- Recruiting
- Phases
- Phase 2
- Enrollment
- 25 participants, estimated
- Lead sponsor
- Daniel Raper, MBBS
- Conditions
- Headaches Associated With Subarachnoid Hemorrhage (SAH)
- Interventions
- Lidocaine hydrochloride, Methylprednisolone sodium succinate
- First posted
- 2025-07-08
- Last updated
- 2026-07-08
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Headache Severity | From baseline to 12-week follow-up | Headache Impact Test-6 (HIT-6) score from baseline (pre-intervention) to 12 weeks postoperatively. Scores range from 36 (no impact) to 78 (severe impact), with higher scores indicating a greater negative impact. |
| Secondary | Headache intensity | From baseline to 12-week follow-up | 11-point Numeric Rating Scale (NRS) score from baseline (pre-intervention) to 12 weeks postoperatively. Scores range from 0 (no pain) to 10 (worst possible pain), with higher scores indicating a greater negative impact. |
| Secondary | Opioid Use | From admission to 12-week follow-up | Total opioid use will be recorded during hospital stay and follow-up. |
| Secondary | Functional Outcome | From discharge to 12-week follow-up | Functional status will be assessed using the modified Rankin Scale at discharge and follow-up. Scores range from 0 (no symptoms) to 6 (death), with lower scores indicating better outcomes. |
| Secondary | Adverse Events Related to Intra-Arterial Injection | From discharge to 12-week follow-up | All procedural and post-procedural complications will be monitored, including symptoms of lidocaine toxicity, new neurological deficits, worsening headache, hemodynamic instability, or allergic reactions. Events will be categorized by severity and attribution to the intervention. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers8
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07054801
GET https://conductscience.org/api/trials/v1/NCT07054801/registered